Sign in

CIK 0001672619 · Non-accelerated filer

Enliven Therapeutics, Inc.

Sign in to watch
Ticker
ELVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
811523849
Phone
650-547-5814
Business address
205 PARK ROAD, BURLINGAME, CA, 94010
Former names
IMARA Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,230,845
in 7 filings, $1.6M under 10b5-1 plans

Net −$2,230,845. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Hohl Benjamin −$887K CHIEF FINANCIAL OFFICER sold 32% of stake
  2. Collins Helen Louise −$737K CHIEF MEDICAL OFFICER sold 38% of stake
  3. Garland J. Scott −$607K Director sold 100% of stake

Reading 37 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-02-17 Heyman Richard A. Director Sale 10b5-1 −1,230 $26.18 $32K 22,647
2026-02-12 Patel Anish CHIEF OPERATING OFFICER Grant or award +20,000 20,000
2026-02-12 Patel Anish CHIEF OPERATING OFFICER Grant or award · Stock Option (right to buy) +120,000 120,000
2026-02-12 Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER Grant or award +18,750 18,750
2026-02-12 Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER Grant or award · Stock Option (right to buy) +112,500 112,500
2026-02-12 Hohl Benjamin CHIEF FINANCIAL OFFICER Grant or award +25,000 61,000
2026-02-12 Hohl Benjamin CHIEF FINANCIAL OFFICER Grant or award · Stock Option (right to buy) +150,000 150,000
2026-02-12 Derynck Mika K Director Grant or award · Stock Option (right to buy) +17,126 17,126
2026-02-12 Ballal Rahul D. Director Grant or award · Stock Option (right to buy) +17,126 17,126
2026-02-12 Collins Helen Louise CHIEF MEDICAL OFFICER Grant or award +25,000 25,000
2026-02-12 Collins Helen Louise CHIEF MEDICAL OFFICER Grant or award · Stock Option (right to buy) +150,000 150,000
2026-02-12 Bauer Jake Director Grant or award · Stock Option (right to buy) +17,126 17,126
2026-02-12 Heyman Richard A. Director Grant or award · Stock Option (right to buy) +19,234 19,234
2026-02-12 Gupta Rishi Director Grant or award · Stock Option (right to buy) +33,989 33,989
2026-02-12 Gupta Rishi Director Grant or award · Stock Option (right to buy) +1,580 1,580
2026-02-12 Kunkel Lori Anne Director Grant or award · Stock Option (right to buy) +17,126 17,126
2026-02-12 Garland J. Scott Director Grant or award · Stock Option (right to buy) +1,427 1,427
2026-02-06 Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER Sale 10b5-1 −5,000 $29.04 $145K 740,188
2026-01-20 Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER Sale 10b5-1 −5,491 $26.37 $145K 759,697
2026-01-20 Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER Sale 10b5-1 −14,509 $26.90 $390K 745,188

Page 6 of 37 · 724 trades